Company Filing History:
Years Active: 2018
Title: Innovations in Dialysis: The Contributions of Anna Bryland
Introduction
Anna Bryland is a notable inventor based in Lomma, Sweden. She has made significant contributions to the field of dialysis through her innovative formulations. With a total of 2 patents, her work focuses on improving the quality and effectiveness of dialysis treatments.
Latest Patents
Anna Bryland's latest patents include a groundbreaking dialysis formulation that introduces a replacement fluid for dialysis treatment. This fluid contains selenium in a concentration of 0.6-1.8 µM and rubidium in a concentration of 1.4-4.2 µM. Notably, the formulation is designed to be essentially free of trace elements such as chromium, manganese, and copper. Additionally, she has developed another dialysis formulation, which may include citrate, comprising selenium and potentially other trace elements like rubidium, cobalt, molybdenum, and zinc. This formulation is intended for use in dialysis treatment, showcasing her commitment to enhancing patient care.
Career Highlights
Anna Bryland is associated with Gambro Lundia AB, a company known for its advancements in dialysis technology. Her work at Gambro has allowed her to focus on innovative solutions that address critical needs in the healthcare sector.
Collaborations
Throughout her career, Anna has collaborated with talented individuals such as Ola Carlsson and Karin Sandin. These partnerships have contributed to her success and the development of her patented inventions.
Conclusion
Anna Bryland's contributions to dialysis formulations represent a significant advancement in medical technology. Her innovative work continues to impact the field positively, improving treatment options for patients worldwide.